Please select the option that best describes you:

In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?  

Does the answer differ if mother remained on TNFi throughout pregnancy?



Answer from: at Academic Institution
Sign in or Register to read more